Results of peripheral vasculopathy, such as Raynaud’s phenomenon, were noticed in postmarketing studies and at the therapeutic dosages of CNS stimulants in all age teams throughout the system of treatment method. Signs and symptoms generally enhanced after dosage reduction or discontinuation of the CNS stimulant.Use or redistribution of any DrugB